Skip to content

Implant Placement With Simultaneous Gum Grafting

The Effect of Implant Placement and Simultaneous Soft Tissue Augmentation in the Esthetic Zone Using Either Connective Tissue Autograft or Acellular Dermal Matrix Allograft on Peri-implant Hard and Soft Tissue Healing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01431144
Enrollment
27
Registered
2011-09-09
Start date
2011-09-30
Completion date
2013-06-30
Last updated
2017-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulous

Keywords

soft tissue thickness, dental implant, soft tissue recession, implant exposure

Brief summary

This study is a comparison of implant placed and simultaneously grafted with either autogenous connective tissue or a connective tissue allograft. The objective is to determine the change in soft tissue thickness and determine if a better result is obtained with the autograft or the allograft. The hypothesis is that there will be no difference in soft tissue thickness over the implant between the autograft and the allograft technique.

Interventions

PROCEDUREconnective tissue autograft

A connective tissue autograft is harvested from the palate and grafted at the site of implant placement on the facial surface.

PROCEDUREconnective tissue allograft

An acellular dermal matrix allograft (Alloderm, BioHorizons, Inc, Birmingham, AL, USA) is grafted at the site of implant placement on the facial surface.

Sponsors

BioHorizons, Inc.
CollaboratorINDUSTRY
University of Louisville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* One edentulous site bordered by 2 teeth needing a dental implant

Exclusion criteria

* Systemic diseases that affect the periodontium * Previous head and neck radiation * Smoking more that 1/2 pack per day * Requires prophylactic antibiotics * Allergy to meds used in study * Previous chemotherapy * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Soft Tissue Thickness Over the Implant1 yearSoft tissue thickness at the facial osseous crest.

Countries

United States

Participant flow

Recruitment details

27 patients were entered, 13 for the test allograft group and 14 for the positive control connective tissue autograft group

Pre-assignment details

There were no exclusions prior to assignment or treatment.

Participants by arm

ArmCount
Connective Tissue Allograft
A connective tissue allograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
13
Connective Tissue Autograft
A connective tissue autograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
14
Total27

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyImplant mobility and removal20

Baseline characteristics

CharacteristicConnective Tissue AutograftConnective Tissue AllograftTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants3 Participants8 Participants
Age, Categorical
Between 18 and 65 years
9 Participants10 Participants19 Participants
Age, Continuous57 years
STANDARD_DEVIATION 10
46 years
STANDARD_DEVIATION 21
52 years
STANDARD_DEVIATION 16
Gender
Female
9 Participants7 Participants16 Participants
Gender
Male
5 Participants6 Participants11 Participants
Region of Enrollment
United States
14 participants13 participants27 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 130 / 14
serious
Total, serious adverse events
0 / 130 / 14

Outcome results

Primary

Soft Tissue Thickness Over the Implant

Soft tissue thickness at the facial osseous crest.

Time frame: 1 year

ArmMeasureValue (MEAN)Dispersion
Connective Tissue AllograftSoft Tissue Thickness Over the Implant0.6 mmStandard Deviation 1.2
Connective Tissue AutograftSoft Tissue Thickness Over the Implant0.4 mmStandard Deviation 0.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026